A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial

Marcos Pedrosa, Star Seyedkazemi, Sven Francque, Arun Sanyal, Mary Rinella, Michael Charlton, Rohit Loomba, Vlad Ratziu, Jossy Kochuparampil, Laurent Fischer, Sujata Vaidyanathan, Quentin M. Anstee*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint Dive into the research topics of 'A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial'. Together they form a unique fingerprint.

Medicine & Life Sciences